TRIHEXYPHENIDYL News

← Back to News Overview

---

TRIHEXYPHENIDYL currently has 0 news articles, with 23 predicted indications.

This page combines the AI-predicted indications for TRIHEXYPHENIDYL with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Evidence level: L5
• Predicted indications (23):
  • basal ganglia disease (99.0%)
  • focal hand dystonia (99.0%)
  • hereditary late onset Parkinson disease (99.0%)
  • early-onset parkinsonism-intellectual disability syndrome (99.0%)
  • juvenile onset Parkinson disease 19A (99.0%)
  • blepharospasm (99.0%)
  • postencephalitic Parkinson disease (99.0%)
  • X-linked parkinsonism-spasticity syndrome (99.0%)
  • parkinsonian-pyramidal syndrome (99.0%)
  • Parkinson disease (99.0%)
  • parkinsonian disorder (99.0%)
  • atypical juvenile parkinsonism (99.0%)
  • hemiparkinsonism-hemiatrophy syndrome (99.0%)
  • attention deficit-hyperactivity disorder (99.9%)
  • faciodigitogenital syndrome (99.9%)
  • attention deficit hyperactivity disorder, inattentive type (99.8%)
  • Rasmussen subacute encephalitis (99.7%)
  • PLA2G6-associated neurodegeneration (99.6%)
  • congenital disorder of glycosylation with defective fucosylation (99.6%)
  • polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (99.6%)
  • retinal dystrophy with or without extraocular anomalies (99.5%)
  • myelitis (99.5%)
  • Charcot-Marie-Tooth disease, demyelinating, type 1G (99.5%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.